Objective To determine whether aggressive treatment initiated early in the course of rheumatoid
factor (RF)–positive or RF‐negative polyarticular juvenile idiopathic arthritis (JIA) can …

Objective There is wide variation in therapeutic approaches to systemic juvenile idiopathic
arthritis (JIA) among North American rheumatologists. Understanding the comparative …

Juvenile idiopathic arthritis (JIA) refers to a group of chronic childhood arthropathies of
unknown etiology, currently classified into subtypes primarily on the basis of clinical features. …

Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In a …

Objective To assess the efficacy and safety of rilonacept, an interleukin‐1 inhibitor, in a
randomized, double‐blind, placebo‐controlled trial. Methods An initial 4‐week double‐blind …

Objective. To determine the elapsed time while receiving aggressive therapy to the first
observation of clinically inactive disease (CID), total duration of CID and potential predictors of …

Background Little is known about the transfer of care process from pediatric to adult
rheumatology for patients with chronic rheumatic disease. The purpose of this study is to examine …

Clinical presentation of patients with PID and autoimmunity is highly variable and requires in-
depth diagnostics and precision medicine approaches.

Background Magnetic resonance imaging (MRI) is often used to diagnose and monitor
treatment effects of juvenile spondyloarthropathy (SpA). Our objective was to describe MRI …

Objective. To follow children with juvenile idiopathic arthritis (JIA) who had completed at least
6 months of the TRial of Early Aggressive Therapy (TREAT) clinical study for an additional …